Vernessa T. Pollard is co-leader of McDermott Will & Emery’s FDA practice. She provides strategic business and regulatory advice to FDA-regulated companies on complex issues related to the development, manufacture, marketing, post-market safety and compliance for FDA-regulated products, including drugs, medical devices and digital health technology. Vernessa counsels companies on product development and premarket strategy, good manufacturing practice and quality system requirements, advertising and promotion, adverse event reporting, FDA warning letters, FDA inspections, recalls, import detentions, corporate compliance programs and regulatory due diligence in mergers and acquisitions. Vernessa is a former Associate Chief Counsel for Enforcement in FDA’s Office of Chief Counsel. She received the LMG Life Sciences, Regulatory Attorney of the Year: FDA Medical Devices, 2018 and has been recognized in numerous Law and Life Sciences publications, including Chambers USA 2014 to 2018, Healthcare: Pharmaceutical/Medical Products Regulatory (District of Columbia). Vernessa received her B.A. in Communications from Howard University and her Juris Doctor from Temple University School of Law.